15th January 2008
Hi all.
Today is the day I am officially leaving the clinical trial I have been in for the past 2 1/2 yrs. That was the CombiRx trial. For those of you unfamiliar with this trial it is the one testing weither Avonex and Copaxone in combination work better than either alone. I have decided to leave this trial due to a major relapse a month or so ago. My neuro. felt that the treatment was not working for me and asked if I would consider a different trial. After a couple of weeks I decided that I would.
Today I am going in for my final MRI and other testing which will complete this study for me. Then it is 3 months off of all med's. Hopefully no relapses during this time. Upon the completion of the 3 month 'purge' I am to begin the trial for fingolimod. The trial last's 2 yrs. I have a one in three chance of recieving the 'real thing'. One either gets .5 mg or 1.25 mg or placebo once a day. Its administered orally...yay!
If any one is interested go to clinical trials .gov The identifier is: NCT00355134 The trial is still recruiting.
Mitch
Today is the day I am officially leaving the clinical trial I have been in for the past 2 1/2 yrs. That was the CombiRx trial. For those of you unfamiliar with this trial it is the one testing weither Avonex and Copaxone in combination work better than either alone. I have decided to leave this trial due to a major relapse a month or so ago. My neuro. felt that the treatment was not working for me and asked if I would consider a different trial. After a couple of weeks I decided that I would.
Today I am going in for my final MRI and other testing which will complete this study for me. Then it is 3 months off of all med's. Hopefully no relapses during this time. Upon the completion of the 3 month 'purge' I am to begin the trial for fingolimod. The trial last's 2 yrs. I have a one in three chance of recieving the 'real thing'. One either gets .5 mg or 1.25 mg or placebo once a day. Its administered orally...yay!
If any one is interested go to clinical trials .gov The identifier is: NCT00355134 The trial is still recruiting.
Mitch
